A Walgreens study, in collaboration with AllianceRx Walgreens Prime showed that adherence to disease-modifying therapies in pregnant MS patients can reduce hospitalization events and costs.
Walgreens’ Brad McElya discusses the retailer's efforts to be a resource for patients living with HIV, as well as those who want to know their HIV status and/or get started on pre-exposure prophylaxis.
With its acquisition of Kashiv Specialty, Amneal will gain a pipeline of 505(b)2 branded products primarily in neurology and endocrinology, as well as a pipeline of complex generics.
The Everstone Group is investing up to $50 million in Series B funding to expand and accelerate Slayback's pipeline of complex generic and specialty pharmaceutical products.